Qiagen N.V.

NYSE:QGEN Stock Report

Market Cap: US$10.0b

Qiagen Future Growth

Future criteria checks 3/6

Qiagen is forecast to grow earnings and revenue by 34.4% and 7.3% per annum respectively. EPS is expected to grow by 35.5% per annum. Return on equity is forecast to be 12% in 3 years.

Key information

34.4%

Earnings growth rate

35.5%

EPS growth rate

Life Sciences earnings growth17.7%
Revenue growth rate7.3%
Future return on equity12.0%
Analyst coverage

Good

Last updated17 Dec 2024

Recent future growth updates

Qiagen N.V. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next

May 03
Qiagen N.V. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next

Recent updates

Qiagen (NYSE:QGEN) Seems To Use Debt Rather Sparingly

Dec 10
Qiagen (NYSE:QGEN) Seems To Use Debt Rather Sparingly

Some Confidence Is Lacking In Qiagen N.V.'s (NYSE:QGEN) P/S

Oct 11
Some Confidence Is Lacking In Qiagen N.V.'s (NYSE:QGEN) P/S

An Intrinsic Calculation For Qiagen N.V. (NYSE:QGEN) Suggests It's 32% Undervalued

Sep 24
An Intrinsic Calculation For Qiagen N.V. (NYSE:QGEN) Suggests It's 32% Undervalued

With Qiagen N.V. (NYSE:QGEN) It Looks Like You'll Get What You Pay For

May 21
With Qiagen N.V. (NYSE:QGEN) It Looks Like You'll Get What You Pay For

Qiagen N.V. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next

May 03
Qiagen N.V. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next

Here's Why Qiagen (NYSE:QGEN) Can Manage Its Debt Responsibly

Mar 20
Here's Why Qiagen (NYSE:QGEN) Can Manage Its Debt Responsibly

Calculating The Intrinsic Value Of Qiagen N.V. (NYSE:QGEN)

Feb 13
Calculating The Intrinsic Value Of Qiagen N.V. (NYSE:QGEN)

Qiagen N.V.'s (NYSE:QGEN) Price Is Out Of Tune With Earnings

Jan 23
Qiagen N.V.'s (NYSE:QGEN) Price Is Out Of Tune With Earnings

Qiagen: No Upsides Slated In FY'23 In Core Business Lines, Reiterate Hold

Sep 09

Qiagen: Major Asset Growth Needed In Post-Covid World

Jun 22

Qiagen: Strong Q4, Derisked Portfolio, Fairly Valued

Feb 14

Qiagen Non-GAAP EPS of $0.53, revenue of $498M, FY23 guidance initiated

Feb 07

Qiagen, Helix partner to advance NGS companion diagnostics in hereditary diseases

Jan 06

Qiagen's test gets FDA nod for companion diagnostic to Mirati's cancer drug Krazati

Dec 13

Qiagen Non-GAAP EPS of $0.53 beats by $0.08, revenue of $500M beats by $17.91M

Nov 07

Qiagen stock down after BHF downgrades rating to Neutral

Oct 10

Earnings and Revenue Growth Forecasts

NYSE:QGEN - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,23550753771417
12/31/20252,09042246465720
12/31/20241,97916629657820
9/30/20241,96693460633N/A
6/30/20241,94073405576N/A
3/31/20241,939337358521N/A
12/31/20231,965341297459N/A
9/30/20231,954332275432N/A
6/30/20231,978337376519N/A
3/31/20231,999353430580N/A
12/31/20222,142423566715N/A
9/30/20222,226488660826N/A
6/30/20222,261539580770N/A
3/31/20222,313563556755N/A
12/31/20212,252513432639N/A
9/30/20212,240311516745N/A
6/30/20212,190480337592N/A
3/31/20212,065449239571N/A
12/31/20201,870359154458N/A
9/30/20201,71319110298N/A
6/30/20201,61214108333N/A
3/31/20201,550-31152302N/A
12/31/20191,526-4156331N/A
9/30/20191,516-2560332N/A
6/30/20191,51119658342N/A
3/31/20191,50718887356N/A
12/31/20181,502190209359N/A
9/30/20181,49690189325N/A
6/30/20181,48278N/A324N/A
3/31/20181,45355N/A275N/A
12/31/20171,41840N/A287N/A
9/30/20171,38789N/A311N/A
6/30/20171,36275N/A323N/A
3/31/20171,34782N/A353N/A
12/31/20161,33880N/A342N/A
9/30/20161,320123N/A328N/A
6/30/20161,296123N/A331N/A
3/31/20161,281126N/A303N/A
12/31/20151,281130N/A317N/A
9/30/20151,293104N/A310N/A
6/30/20151,315105N/A303N/A
3/31/20151,326113N/A305N/A
12/31/20141,345116N/A288N/A
9/30/20141,345151N/A291N/A
6/30/20141,331157N/A284N/A
3/31/20141,31572N/A259N/A
12/31/20131,30269N/A259N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: QGEN's forecast earnings growth (34.4% per year) is above the savings rate (2.6%).

Earnings vs Market: QGEN's earnings (34.4% per year) are forecast to grow faster than the US market (15.3% per year).

High Growth Earnings: QGEN's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: QGEN's revenue (7.3% per year) is forecast to grow slower than the US market (9.2% per year).

High Growth Revenue: QGEN's revenue (7.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: QGEN's Return on Equity is forecast to be low in 3 years time (12%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 02:06
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Qiagen N.V. is covered by 63 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel OwczarskiAvondale Partners
Catherine Ramsey SchulteBaird
Carla BänzigerBank Vontobel AG